[Federal Register: November 18, 2003 (Volume 68, Number 222)]
[Notices]               
[Page 65075]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18no03-71]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Anesthetic and Life Support Drugs Advisory Committee; Amendment 
of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Anesthetic and Life Support Drugs 
Advisory Committee. This meeting was announced in the Federal Register 
of October 8, 2003 (68 FR 58115). The amendment is being made to 
reflect a change in the Agenda portion of the document. There are no 
other changes.

FOR FURTHER INFORMATION CONTACT: Johanna Clifford, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville MD 20857, 301-827-7001, or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
12529. Please call the Information Line for up-to-date information on 
this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of October 8, 2003, 
FDA announced that a meeting of the Anesthetic and Life Support Drugs 
Advisory Committee would be held on November 18 and 19, 2003. On pages 
58115-58116, in the third column, the Agenda portion of the meeting is 
amended to read as follows:
    Agenda: On November 18, 2003, the committee will discuss the 
evaluation and communication of risk related to QTc prolongation by 
Droperidol (INAPSINE) Akorn, Inc.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: November 14, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-28870 Filed 11-14-03; 8:45 am]

BILLING CODE 4160-01-S